Federated Hermes, Inc. Cyma Bay Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$12.63 - $24.47 $37 - $73	3 New	3 $0
Q1 2022 May 13, 2022	SELL	$2.77 - $3.64 $214,406 - $281,746	-77,403 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $249,876 - $355,860	77,361 Added 184192.86%	77,403 $262,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $1,669 - $2,126	-481 Reduced 91.97%	42 $1,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $1,205 - $1,505	-306 Reduced 36.91%	523 $2,000
Q1 2021 May 13, 2021	BUY	$4.23 - $6.55 $2,131 - $3,301	504 Added 155.08%	829 $4,000
Q4 2020 Feb 12, 2021	SELL	$5.73 - $9.03 $137 - $216	-24 Reduced 6.88%	325 $2,000
Q3 2020 Nov 12, 2020	SELL	$3.32 - $7.24 $557 - $1,216	-168 Reduced 32.5%	349 $3,000
Q2 2020 Aug 13, 2020	SELL	$1.41 - $4.25 $175,576 - $529,218	-124,522 Reduced 99.59%	517 $2,000
Q1 2020 May 13, 2020	BUY	$1.25 - $2.02 $33,063 - $53,431	26,451 Added 26.83%	125,039 $185,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $82,706 - $368,757	62,185 Added 170.82%	98,588 $193,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $169,410 - $238,564	33,088 Added 998.13%	36,403 $186,000
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $17,442 - $39,381	2,883 Added 667.36%	3,315 $24,000
Q1 2019 May 10, 2019	BUY	$8.16 - $13.42 $3,525 - $5,797	432 New	432 $6,000
Q2 2018 Aug 10, 2018	SELL	$10.66 - $14.38 $1,833 - $2,473	-172 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$9.0 - $15.16 $1,548 - $2,607	172 New	172 $2,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.